Accessibility Menu
Telescope Innovations logo

Telescope Innovations(OTC) TELIF

Market Cap$30.87MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-19%
5 YearN/A
1 Year+35%
1 Month+28%
$0.37
-4.16%
-0.02Today
Telescope Innovations last closing stock price
MetricPriceDate
Last closeUSD 0.382026-09-02
Telescope Innovations stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.64%USD 0.372026-08-26
1 month+28.38%USD 0.302026-08-03
3 month-40.5%USD 0.642026-06-04
Year to date+49.08%USD 0.262025-12-31
1 year+34.91%USD 0.282025-09-02
3 year+124.71%USD 0.172023-08-31
Since inception-18.71%USD 0.472022-05-24

Telescope Innovations Financials at a Glance

Market Cap

$30.87MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$7.30M

Net Income (TTM)

-CA$4.09M

EPS (TTM)

-$0.04

P/E Ratio

-9.29

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.37

Volume

90,697

Open

$0.34

Previous Close

$0.37

Daily Range

$0.34 - $0.40

52-Week Range

$0.21 - $0.77

Estimated Earnings Date

Apr 21, 2026

TELIF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Telescope Innovations

Telescope Innovations Corp. is a biotechnology firm focused on developing synthetic methods for producing pharmaceutical compounds aimed at treating mental health conditions. Based in Vancouver, Canada, the company is positioned to address a growing need in the healthcare sector.

Products and Services
  • Innovative synthetic methods for pharmaceutical compounds
  • Targeted treatments for mental health conditions
  • Research and development in chemical technology
Growth Outlook
  • Market demand for mental health treatments is increasing
  • Potential for partnerships with healthcare providers
  • Expansion of product pipeline expected in the coming years
Financial Highlights
  • Recent quarterly revenue of CAD 1,203,599, showing market interest
  • Trailing twelve months (TTM) revenue of CAD 5,000,000, indicating growth potential
  • Current ratio of 2.59, suggesting strong liquidity position
Telescope Innovations Corp. operates in a critical sector with a focus on mental health, an area of increasing concern globally. The company's innovative approach to pharmaceutical development positions it well for future growth. Recent financial data indicates a solid revenue stream, with a TTM revenue of CAD 5,000,000, reflecting the company's ability to attract market interest. The current ratio of 2.59 further highlights a strong liquidity position, which is essential for ongoing operations and potential expansion. As the demand for effective mental health treatments continues to rise, Telescope Innovations Corp. is strategically positioned to capitalize on this trend, making it an intriguing option for potential investors.
AI Generated • Aug 19, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

CEO

Henry Dubina

Website

www.telescopeinnovations.com

Headquarters

Vancouver, BC V6T 1Z3, CA

TELIF Financials

Key Financial Metrics (TTM)

Gross Margin

2.22%

Operating Margin

-70.61%

Net Income Margin

-56.03%

Return on Equity

-101.95%

Return on Capital

-31.70%

Return on Assets

-59.78%

Earnings Yield

-10.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$30.87MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

80.81M

Volume

90.70K

Avg. Volume

161.15K

Financials (TTM)

Gross Profit

CA$1.39M

Operating Income

-CA$4.87M

EBITDA

-CA$3.98M

Operating Cash Flow

-CA$5.93M

Capital Expenditure

-CA$571.60K

Free Cash Flow

-CA$6.31M

Cash & ST Invst.

CA$1.34M

Total Debt

CA$2.72M

Telescope Innovations Performance Analysis

Telescope Innovations annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-08-31CAD 468,056N/A
20232023-08-31CAD 2,096,994348.0%
20242024-08-31CAD 3,135,31949.5%
20252025-08-31CAD 3,424,5719.2%
Telescope Innovations sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-08-3135.8%
Q12025-11-3042.2%
Q22026-02-28-44.1%
Q32026-05-31-20.1%
Telescope Innovations annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-08-31CAD -0.09N/A
20232023-08-31CAD -0.01-89.2%
20242024-08-31CAD -0.0285.1%
20252025-08-31CAD -0.0211.8%
Telescope Innovations sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-08-31100.0%
Q12025-11-30N/A
Q22026-02-2813.7%
Q32026-05-314.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

CA$1.20M

-13.7%

Gross Profit

-CA$205.28K

-114.7%

Gross Margin

-17.06%

N/A

Market Cap

$30.87MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$6.17M

N/A

Employees

5

N/A

Net Income

-CA$1.41M

-180.4%

EBITDA

-CA$2.01M

-613.0%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

CA$1.34M

+20.3%

Total Debt

CA$2.72M

+22.4%

Accounts Receivable

CA$1.62M

+347.5%

Inventory

CA$300.53K

+6.7%

Long Term Debt

CA$2.04M

-8.3%

Short Term Debt

CA$680.16K

N/A

Return on Assets

-59.78%

N/A

Return on Invested Capital

-95.02%

N/A

Free Cash Flow

-CA$1.30M

-268.1%

Operating Cash Flow

-CA$1.20M

-284.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ZHCLFZenith Capital Corp.
$0.17+0.00%
MYCOFNoveris Health Sciences Inc.
$0.73+0.00%
CLCSCell Source, Inc.
$0.74-17.22%
PPCBPropanc Biopharma, Inc.
$1.02-0.97%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$10.38+0.11%
NVDANvidia
$228.45+0.02%
SPCXSpace Exploration Technologies
$149.74+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$11.01+0.06%

Questions About TELIF

What is the current price of Telescope Innovations?

Telescope Innovations is trading at $0.37 per share.

What is the 52-week range for Telescope Innovations?

Over the past 52 weeks, Telescope Innovations has traded between $0.21 and $0.77.

How much debt does Telescope Innovations have?

As of the most recent reporting period, Telescope Innovations reported total debt of CA$1.97M.

How much cash does Telescope Innovations have on hand?

Telescope Innovations reported CA$968.95K in cash and cash equivalents in its most recent financial results.

What is Telescope Innovations’s dividend yield?

Telescope Innovations does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services